Biopsy Devices - EU Analysis and Market Forecasts Summary Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. Beyond providing a general analysis and forecast for each device segment in European countries (France, Germany, Italy, Spain, and the UK) from 2013-2022, this report offers a more detailed approach by assessing the adoption patterns of the different biopsy procedure types for specific cancer indications in specific geographies. This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions Answered - What are the procedure volumes for different biopsy procedures in 5EU countries? How will the volumes change in the next five years? - Growth in the biopsy devices market is driven by an increasing number of cancer incident cases. What are the current numbers of cancer diagnosed cases in 5EU countries? How will the numbers change in the upcoming years? - Biopsy guns are most frequently used biopsy devices and core needle biopsy devices gain popularity over fine needle aspiration devices. What are the current adoption trends of different types of biopsy device in 5EU countries? How will the adoption trends evolve in the near future? - There are various types of biopsy devices and different companies have a different strategic product focus. Who are the leading players in the biopsy devices market? Reasons To Buy - "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Executive Summary 2.1 Market Dynamics 2.2 Key Players in the Global Biopsy Devices Market 2.3 Future Growth 2.4 Future Outlook 2.5 What Do Physicians Think? 3 Introduction 3.1 Overview 3.2 Catalyst 3.3 Related Reports 4 Industry Overview 4.1 Types of Biopsies 4.1.1 Surgical Biopsy 4.1.2 Fine Needle Aspiration 4.1.3 Core Needle Biopsy 4.1.4 Vacuum-Assisted Biopsy 4.2 Market Access to Cancer Screening Programs 4.2.1 Regulation 4.2.2 Biopsy Device Adoption Patterns 4.2.3 Reimbursement Trends 4.2.4 Regulatory Issues/Recalls 4.3 Mergers and Acquisitions/Key Partnerships 4.3.1 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery 4.3.2 Argon Medical Devices Acquires Promex Technologies 4.3.3 GTCR Sells Devicor Medical Products 4.3.4 Becton Dickinson Completes Acquisition of CareFusion 4.4 Economic Impact of Cancer Screening and Treatment 4.5 Additional Indications for Biopsy Devices 5 Unmet Needs and Market Opportunity Analysis 5.1 Overview 5.2 Minimise Prostate Biopsy Complications 5.3 More Efficient Screening Tests for Cancer 5.4 More Efficient Screening Guidelines for Thyroid Cancer 5.5 Less Invasive Screening Tests With Better Accuracy 6 Competitive Assessment 6.1 Company Share Analysis 6.1.1 Vacuum-Assisted Biopsy Market Share 6.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share 6.2 Classification Based on System 6.2.1 Vacuum-Assisted Biopsy Devices 6.2.2 Core Needle Biopsy Devices 6.2.3 Fine Needle Aspiration Devices 6.3 Major Players 6.3.1 Argon Medical Devices 6.3.2 Becton, Dickinson and Company 6.3.3 Boston Scientific 6.3.4 Cook Medical 6.3.5 C. R. Bard 6.3.6 Gallini Medical Devices 6.3.7 Hologic 6.3.8 Leica Biosystems 6.3.9 Stryker 6.3.10 TSK Laboratory 6.3.11 Zamar Care 6.4 Pipeline Products Assessment 6.4.1 Overview 6.4.2 Optical Biopsy 6.4.3 Liquid Biopsy 6.5 Emerging Players 7 Market Outlook 7.1 Biopsy Procedure Trends 7.1.1 5EU 7.2 Market Drivers and Barriers 7.2.1 Market Drivers 7.2.2 Market Barriers 7.3 Market Outlook by Segment 7.3.1 Fine Needle Aspiration 7.3.2 Core Needle Biopsy 7.3.3 Vacuum-Assisted Biopsy 7.3.4 Biopsy Guns 7.3.5 Biopsy Forceps and Punches 7.4 Market Outlook by Geography 7.4.1 France 7.4.2 Germany 7.4.3 Italy 7.4.4 Spain 7.4.5 UK 8 Appendix 8.1 Bibliography 8.2 Abbreviations 8.3 Report Methodology 8.3.1 Overview 8.3.2 Coverage 8.3.3 Primary Research 8.3.4 Secondary Research 8.3.5 Forecasting Methodology 8.4 Key Opinion Leaders Included in This Study 8.5 About the Authors 8.5.1 Yizhe Xu, MSc, Research Analyst, Medical Devices 8.5.2 Linda Tian, MSc, Managing Analyst, Medical Devices 8.5.3 Tyler Fletcher, Global Head of Medical Devices 8.6 About GlobalData 8.7 Contact Us 8.8 Disclaimer
List of Tables
Table 1: Overview of Global Biopsy Devices Market*, 2015 and 2022 Table 2: VAB, Global Market Share, 2015 Table 3: CNB/FNA, Global Market Share, 2015 Table 4: Company Profile - Argon Medical Devices Table 5: Argon Medical Devices, SWOT Analysis, 2016 Table 6: Product Portfolio - Argon Medical Devices Table 7: Company Profile - BD Table 8: BD, SWOT Analysis, 2016 Table 9: Product Portfolio - BD Table 10: Company Profile - Boston Scientific Table 11: Boston Scientific SWOT Analysis, 2016 Table 12: Product Portfolio - Boston Scientific Table 13: Company Profile - Cook Medical Table 14: Cook Medical, SWOT Analysis, 2016 Table 15: Product Portfolio - Cook Medical Table 16: Company Profile - C. R. Bard Table 17: C. R. Bard, SWOT Analysis, 2016 Table 18: Product Portfolio - C. R. Bard Table 19: Company Profile - Gallini Medical Devices Table 20: Gallini Medical Devices SWOT Analysis, 2016 Table 21: Product Portfolio - Gallini Medical Devices Table 22: Company Profile - Hologic Table 23: Hologic SWOT Analysis, 2016 Table 24: Product Portfolio - Hologic Table 25: Company Profile - Leica Biosystems Table 26: Leica Biosystems, SWOT Analysis, 2016 Table 27: Product Portfolio - Leica Biosystems Table 28: Company Profile - Stryker Table 29: Sktryker SWOT Analysis, 2016 Table 30: Product Portfolio - Stryker Table 31: Company Profile - TSK Laboratory Table 32: TSK Laboratory SWOT Analysis, 2016 Table 33: Product Portfolio - TSK Laboratory Table 34: Company Profile - Zamar Care Table 35: Zamar Care SWOT Analysis, 2016 Table 36: Product Portfolio - Zamar Care Table 37: Emerging Players in Liquid Biopsy Market Table 38: Age Demographics, Age >65 Years, Global, 2013 Table 39: Global FNA Device Sales ($m) Forecast, 2013-2022 Table 40: Global CNB Device Sales ($m) Forecast, 2013-2022 Table 41: Global VAB Device Sales ($m) Forecast, 2013-2022 Table 42: Global Biopsy Guns Sales ($m) Forecast, 2013-2022 Table 43: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022 Table 44: France Biopsy Devices Sales ($m) Forecast, 2013-2022 Table 45: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022 Table 46: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022 Table 47: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022 Table 48: UK Biopsy Devices Sales ($m) Forecast, 2013-2022
List of Figures
Figure 1: Composition of Global Biopsy Devices Procedures, 2015 and 2022 Figure 2 : Biopsy Devices, Global Market Share, 2015 Figure 3: VAB, Global Market Share, 2015 Figure 4: CNB/FNA, Global Market Share, 2015 Figure 5: Biopsy Procedure Volumes: Prostate, 5EU, 2013-2022 Figure 6: Biopsy Procedure Volume: Breast, 5EU, 2013-2022 Figure 7: Biopsy Procedure Volume: Lung, 5EU, 2013-2022 Figure 8: Biopsy Procedure Volume: Colorectal, 5EU, 2013-2022 Figure 9: Biopsy Procedure Volumes: Liver, 5EU, 2013-2022 Figure 10: Biopsy Procedure Volume: Thyroid, 5EU, 2013-2022 Figure 11: Global FNA Device Sales ($m) Forecast, 2013-2022 Figure 12: Global CNB Device Sales ($m) Forecast, 2013-2022 Figure 13: Global VAB Device Sales ($m) Forecast, 2013-2022 Figure 14: Global Biopsy Guns Sales ($m) Forecast, 2013-2022 Figure 15: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022 Figure 16: France Biopsy Devices Sales ($m) Forecast, 2013-2022 Figure 17: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022 Figure 18: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022 Figure 19: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022 Figure 20: UK Biopsy Devices Sales ($m) Forecast, 2013-2022
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commercRead More...
Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmaceRead More...
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.